FIELD: organic chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely, to an application of a compound by the formula (I) for inhibiting interaction of TRAF6 with UBC13, wherein X is selected from the group consisting of N and CH; R1 is selected from the group consisting of hydrogen, a (C1-C6)alkyl, a (C1-C6)halogenalkyl; R2 and R3 are independently selected from the group consisting of a linear (C1-C6)alkyl; n constitutes 2; Z is selected from the group consisting of C=O; Z is C=O; A is selected from the group consisting of –N(R4)(R5) and R4 constitutes hydrogen or a (C1-C6)alkyl; R5 is selected from the group consisting of a (C6-C10)aryl(C1-C6)alkyl, a furanyl(C1-C6)alkyl, a thiophenyl(C1-C6)alkyl, and an indolyl(C1-C6)alkyl, optionally substituted with one or more identical or different substituents selected from the group consisting of halogen, a (C1-C4)alkyl; R6 constitutes a (C1-C4)alkyl; Y is selected from the group consisting of N-B, CH-B, and O; B is selected from the group consisting of a (C6-C10)aryl, pyridinyl, a (C6-C10)aryl(C1-C6)alkyl, a pyridinyl(C1-C6)alkyl, a furanyl(C1-C6)alkyl, and a (C1-C6)alkyl, optionally substituted with one or more identical or different substituents selected from the group consisting of halogen, a (C1-C4)alkyl, a (C1-C4)halogenalkyl, and -OR6; p and q constitutes an integer from 1 to 2. The invention also relates to a compound by the formula (I), wherein the values of radicals have the values specified in the claim, and specific compounds.
EFFECT: inhibition of interaction of TRAF6 with UBC13 by a compound by the formula (I) in treatment of arthritis, psoriasis, and some types of cancer.
12 cl, 20 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
ACIDIFIED INDANYLAMINES AND THEIR USE AS PHARMACEUTICAL PREPARATIONS | 2002 |
|
RU2339614C2 |
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE | 2020 |
|
RU2807611C2 |
FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
HETEROAROMATIC COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE MODULATORS AND METHODS OF USE | 2013 |
|
RU2665036C9 |
PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2532161C2 |
TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
Authors
Dates
2022-04-15—Published
2017-09-18—Filed